Pierre Fabre Ltd.
🇬🇧United Kingdom
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)UK ENcorafenib and BInimetinib Real-world Study in Melanoma
Recruiting
- Conditions
- Metastatic Melanoma, BRAF V600 Mutation Positive
- Interventions
- First Posted Date
- 2025-06-15
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Pierre Fabre Ltd
- Target Recruit Count
- 50
- Registration Number
- NCT07022457
- Locations
- 🇬🇧
Southend University Hospital, Westcliff-on-Sea, Essex, United Kingdom
🇬🇧Queen Elizabeth Hospital, Birmingham, United Kingdom
🇬🇧Addenbrookes Hospital, Cambridge, United Kingdom
News
No news found